CIK 1440771
Stonepine Capital Management, LLC
Institutional 13F holdings & portfolio
Holdings
64
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–50 of 64
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| VSTM | VERASTEM INC | 2.7M | $1M+ | SH |
| ADMA | ADMA BIOLOGICS INC | 740K | $1M+ | SH |
| EOLS | EVOLUS INC | 1.6M | $1M+ | SH |
| ZVRA | ZEVRA THERAPEUTICS INC | 569K | $1M+ | SH |
| IKT | INHIBIKASE THERAPEUTICS INC | 2.3M | $1M+ | SH |
| INDV | INDIVIOR PLC | 100K | $1M+ | SH |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 390K | $1M+ | SH |
| KZIA | KAZIA THERAPEUTICS LTD | 460K | $1M+ | SH |
| XOMA | XOMA ROYALTY CORPORATION | 115K | $1M+ | SH |
| VRCA | VERRICA PHARMACEUTICALS INC | 354K | $1M+ | SH |
| HELP | CYBIN INC | 340K | $1M+ | SH |
| TELA | TELA BIO INC | 2.4M | $1M+ | SH |
| ACAD | ACADIA PHARMACEUTICALS INC | 100K | $1M+ | SH |
| CRSP | CRISPR THERAPEUTICS AG | 50K | $1M+ | SH (Call) |
| SRZN | SURROZEN INC | 114K | $1M+ | SH |
| ARE | ALEXANDRIA REAL ESTATE EQ IN | 50K | $1M+ | SH (Call) |
| XFOR | X4 PHARMACEUTICALS INC | 594K | $1M+ | SH |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 100K | $1M+ | SH (Call) |
| AYTU | AYTU BIOPHARMA INC | 814K | $1M+ | SH |
| NKTR | NEKTAR THERAPEUTICS | 50K | $1M+ | SH (Call) |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | 200K | $1M+ | SH |
| ACET | ADICET BIO INC | 220K | $1M+ | SH |
| SPRB | SPRUCE BIOSCIENCES INC | 20K | $1M+ | SH |
| HRTX | HERON THERAPEUTICS INC | 1.2M | $1M+ | SH |
| ENTA | ENANTA PHARMACEUTICALS INC | 100K | $1M+ | SH |
| PMVP | PMV PHARMACEUTICALS INC | 1.2M | $1M+ | SH |
| CAMP | CAMP4 THERAPEUTICS CORP | 229K | $1M+ | SH |
| ELDN | ELEDON PHARMACEUTICALS INC | 893K | $1M+ | SH |
| MIST | MILESTONE PHARMACEUTICALS IN | 663K | $1M+ | SH |
| OABI | OMNIAB INC | 701K | $1M+ | SH |
| QNRX | QUOIN PHARMACEUTICALS LTD | 78K | $1M+ | SH |
| LUNG | PULMONX CORP | 486K | $1M+ | SH |
| GERN | GERON CORP | 806K | $1M+ | SH |
| ABEO | ABEONA THERAPEUTICS INC | 200K | $1M+ | SH (Call) |
| CBIO | CRESCENT BIOPHARMA INC. | 88K | $1M+ | SH |
| KZR | KEZAR LIFE SCIENCES INC | 156K | $500K+ | SH |
| EDSA | EDESA BIOTECH INC | 688K | $500K+ | SH |
| BOLD | BOUNDLESS BIO INC | 710K | $500K+ | SH |
| RADX | RADIOPHARM THERANOSTICS LTD | 51.0M | $500K+ | SH |
| SMLR | SEMLER SCIENTIFIC INC | 50K | $500K+ | SH |
| MXCT | MAXCYTE INC | 469K | $500K+ | SH |
| ANTX | AN2 THERAPEUTICS INC | 628K | $500K+ | SH |
| GOSS | GOSSAMER BIO INC | 205K | $500K+ | SH |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 464K | $500K+ | SH |
| BIOA | BIOAGE LABS INC | 45K | $500K+ | SH |
| MNKD | MANNKIND CORP | 86K | $100K–$500K | SH |
| CGEN | COMPUGEN LTD | 305K | $100K–$500K | SH |
| CDXS | CODEXIS INC | 256K | $100K–$500K | SH |
| INAB | IN8BIO INC | 165K | $100K–$500K | SH |
| FENC | FENNEC PHARMACEUTICALS INC | 50K | $100K–$500K | SH |